Skip to content
DraconiticResearch
Search Sources API
186,546 studies31 sourcesUpdated 46 min ago
PreprintAll rights reservedbioRxiv

Early dynamics of a neutrophil interferon program drive immunotherapy resistance and limit durable anti-tumor immunity

  • Y. Gao
  • E. Anning
  • L. Wang
  • Y. CHENG
  • L. Wu
  • J. Wang
  • F. Liu
  • Z. Xu
  • X. Hao
  • J. Liu
  • L. Yu
  • Y. Ding
20 more authors
  • W. Zhang1
  • D. G. Edwards
  • Y.-H. Wu
  • H. L. Chan
  • D. Hoffman
  • S. Wang
  • T. D. Lee
  • L. B. Dominguez
  • N. Peled
  • X. Li
  • X. Chen
  • C. H. Rivas
  • N. Zhao
  • S. J. Calderon
  • D. A. Pedroza
  • A. Smith
  • N. Guan
  • Z. Liu
  • J. Rosen
  • X. Zhang1
  1. 1Baylor College of Medicine
Read full textPDFDOICite

Related

  1. Corticosteroids drive oral candidiasis by impairing type-17 immunity without inducing interferon-gammopathy
    Ashira Lubkin, Abigail Fellows, Lucas dos Santos Dias +2
    mBioPeer-reviewedPublisher termsFull textInfectious diseaseCrossref
  2. Interferon-λ inhibits immunopathology and boosts T cell–mediated immunity in a mouse model of mucosal viral infection
    Emily Feng, Alexa Mansour, Elizabeth Balint +10
    The Journal of clinical investigationPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Interferon regulatory factor 3 beyond innate immunity: Regulation in obesity and metabolic disorders
    Heng Li, Yongliang Zhang, Hong Yong Peh
    Seminars in ImmunologyPeer-reviewedCC BY-NC5 citedEpidemiology & public healthHAL
  4. Editorial: Community series in unveiling the next generation of cancer immunity & immunotherapy in lung cancer, volume II
    Nethaji Muniraj, Mohanraj Sadasivam, Chellappagounder Thangavel
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  5. Strategic engineering B cell immunity for cancer immunotherapy
    Chengyi Li, Hrishi Venkatesh, Lam Trieu +1
    Journal of controlled release : official journal of the Controlled Release SocietyPeer-reviewedLicence not statedFull textOncologyPMC

Cite

BibTeXRIS
BibTeX
@misc{gao2026early,
  title = {{Early dynamics of a neutrophil interferon program drive immunotherapy resistance and limit durable anti-tumor immunity}},
  author = {Y. Gao and E. Anning and L. Wang and Y. CHENG and L. Wu and J. Wang and F. Liu and Z. Xu and X. Hao and J. Liu and L. Yu and Y. Ding and W. Zhang and D. G. Edwards and Y.-H. Wu and H. L. Chan and D. Hoffman and S. Wang and T. D. Lee and L. B. Dominguez and N. Peled and X. Li and X. Chen and C. H. Rivas and N. Zhao and S. J. Calderon and D. A. Pedroza and A. Smith and N. Guan and Z. Liu and J. Rosen and X. Zhang},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.30.755684},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.30.755684v1},
}
RIS
TY  - UNPB
TI  - Early dynamics of a neutrophil interferon program drive immunotherapy resistance and limit durable anti-tumor immunity
AU  - Y. Gao
AU  - E. Anning
AU  - L. Wang
AU  - Y. CHENG
AU  - L. Wu
AU  - J. Wang
AU  - F. Liu
AU  - Z. Xu
AU  - X. Hao
AU  - J. Liu
AU  - L. Yu
AU  - Y. Ding
AU  - W. Zhang
AU  - D. G. Edwards
AU  - Y.-H. Wu
AU  - H. L. Chan
AU  - D. Hoffman
AU  - S. Wang
AU  - T. D. Lee
AU  - L. B. Dominguez
AU  - N. Peled
AU  - X. Li
AU  - X. Chen
AU  - C. H. Rivas
AU  - N. Zhao
AU  - S. J. Calderon
AU  - D. A. Pedroza
AU  - A. Smith
AU  - N. Guan
AU  - Z. Liu
AU  - J. Rosen
AU  - X. Zhang
PY  - 2026
DA  - 2026/09/30
PB  - bioRxiv
DO  - 10.64898/2026.09.30.755684
UR  - https://www.biorxiv.org/content/10.64898/2026.09.30.755684v1
ER  -